TrialJournal of lipid research2012

LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.

Ariel Brautbar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.